default author photo

John Aponte

PATH

2201 Westlake Avenue, Suite 200

Seattle, WA 98121

United States

SCHOLARLY PAPERS

1

DOWNLOADS

161

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Safety and Immunogenicity of a Nipah Virus Vaccine (Hev-Sg-V) in Adults: A Single-Centre, Randomised, Observer-Blind, Placebo-Controlled, Phase 1 Study

Number of pages: 31 Posted: 30 May 2024
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, PATH, PATH, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Auro Vaccines LLC, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, PATH, PATH, PATH, PATH, PATH, PATH, PATH and PATH
Downloads 161 (464,454)
Citation 1

Abstract:

Loading...

Nipah virus, vaccine, randomised clinical trial, infectious diseases